Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury

Journal of Neurochemistry

Volumn 106, Issue 3, 2008, Pages 1378-1387

  Onishchenko, Natalia ^a   Karpova, Nina ^b   Sabri, Farideh ^a   Castrén, Eero ^b   Ceccatelli, Sandra ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

BDNF; Depression; Environment; Epigenetic changes; Fluoxetine; Mice

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; DNA; DRINKING WATER; FLUOXETINE; MESSENGER RNA; METHYLMERCURY;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DEPRESSION; DEVELOPMENTAL DISORDER; DISEASE PREDISPOSITION; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; EPIGENETICS; FORCED SWIMMING TEST; GENE EXPRESSION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERINATAL PERIOD; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; EPIGENESIS, GENETIC; FEMALE; FLUOXETINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMOBILIZATION; MALE; METHYLMERCURY COMPOUNDS; MICE; MICE, INBRED C57BL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

MUS;

EID: 48249105104     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05484.x     Document Type: Article

References (51)

1. Aid T., Kazantseva A., Piirsoo M., Palm K. Timmusk T. (2007) Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85, 525 535.
2. Alpert J. E., Maddocks A., Nierenberg A. A., O'Sullivan R., Pava J. A., Worthington J. J. 3rd, Biederman J., Rosenbaum J. F. Fava M. (1996) Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res. 62, 213 219.
3. Ansorge M. S., Hen R. Gingrich J. A. (2007) Neurodevelopmental origins of depressive disorders. Curr. Opin. Pharmacol. 7, 8 17.
4. Anway M. D., Cupp A. S., Uzumcu M. Skinner M. K. (2005) Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308, 1466 1469.
5. Bernstein B. E., Meissner A. Lander E. S. (2007) The mammalian epigenome. Cell 128, 669 681.
6. Björnberg K. A., Vahter M., Grawe K. P. Berglund M. (2005) Methyl mercury exposure in Swedish women with high fish consumption. Sci. Total Environ. 341, 45 52.
7. Castrén E., Voikar V. Rantamaki T. (2007) Role of neurotrophic factors in depression. Curr. Opin. Pharmacol. 7, 18 21.
8. Chakrabarti S. K., James J. C. Mirmira R. G. (2002) Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J. Biol. Chem. 277, 13286 13293.
9. Chen B., Dowlatshahi D., MacQueen G. M., Wang J. F. Young L. T. (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50, 260 265.
10. Chen W. G., Chang Q., Lin Y., Meissner A., West A. E., Griffith E. C., Jaenisch R. Greenberg M. E. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302, 885 889.
11. Clark S. J., Harrison J., Paul C. L. Frommer M. (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22, 2990 2997.
12. Colvis C. M., Pollock J. D., Goodman R. H. et al. (2005) Epigenetic mechanisms and gene networks in the nervous system. J. Neurosci. 25, 10379 10389.
13. Crowley J. J., Blendy J. A. Lucki I. (2005) Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl.) 183, 257 264.
14. Cryan J. F., Markou A. Lucki I. (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23, 238 245.
15. Dopheide J. A. (2006) Recognizing and treating depression in children and adolescents. Am. J. Health Syst. Pharm. 63, 233 243.
16. Dulawa S. C., Holick K. A., Gundersen B. Hen R. (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29, 1321 1330.
17. Duman R. S. Monteggia L. M. (2006) A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59, 1116 1127.
18. Frommer M., McDonald L. E., Millar D. S., Collis C. M., Watt F., Grigg G. W., Molloy P. L. Paul C. L. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl Acad. Sci. USA 89, 1827 1831.
19. Gonzalgo M. L. Jones P. A. (1997) Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. 25, 2529 2531.
20. Grandjean P. Landrigan P. J. (2006) Developmental neurotoxicity of industrial chemicals. Lancet 368, 2167 2178.
21. Grønli J., Bramham C., Murison R., Kanhema T., Fiske E., Bjorvatn B., Ursin R. Portas C. M. (2006) Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol. Biochem. Behav. 85, 842 849.
22. Hofer M., Pagliusi S. R., Hohn A., Leibrock J. Barde Y. A. (1990) Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9, 2459 2464.
23. Karege F., Vaudan G., Schwald M., Perroud N. La Harpe R. (2005) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 136, 29 37.
24. Knable M. B., Barci B. M., Webster M. J., Meador-Woodruff J. Torrey E. F. (2004) Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol. Psychiatry 9, 609 620.
25. Kobal Grum D., Kobal A. B., Arneric N., Horvat M., Zenko B., Dzeroski S. Osredkar J. (2006) Personality traits in miners with past occupational elemental mercury exposure. Environ. Health Perspect. 114, 290 296.
26. Kouzarides T. (2007) Chromatin modifications and their function. Cell 128, 693 705.
27. Kumar A., Choi K. H., Renthal W. et al. (2005) Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48, 303 314.
28. Lachner M. Jenuwein T. (2002) The many faces of histone lysine methylation. Curr. Opin. Cell Biol. 14, 286 298.
29. Lapham L. W., Cernichiari E., Cox C., Myers G. J., Baggs R. B., Brewer R., Shamlaye C. F., Davidson P. W. Clarkson T. W. (1995) An analysis of autopsy brain tissue from infants prenatally exposed to methymercury. Neurotoxicology 16, 689 704.
30. Levenson J. M., O'Riordan K. J., Brown K. D., Trinh M. A., Molfese D. L. Sweatt J. D. (2004) Regulation of histone acetylation during memory formation in the hippocampus. J. Biol. Chem. 279, 40545 40559.
31. Mahaffey K. R. (2005) Mercury exposure: medical and public health issues. Trans. Am. Clin. Climatol. Assoc. 116, 127 153.
32. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., Fan G. Sun Y. E. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890 893.
33. McEwen B. S. (1999) Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22, 105 122.
34. Meaney M. J. (2001) Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev. Neurosci. 24, 1161 1192.
35. Mendola P., Selevan S. G., Gutter S. Rice D. (2002) Environmental factors associated with a spectrum of neurodevelopmental deficits. Ment. Retard. Dev. Disabil. Res. Rev. 8, 188 197.
36. National Research Council (2000) Scientific frontiers in developmental toxicology and risk assessment. National Academy Press, Washington, DC.
37. Nestler E. J., Barrot M., DiLeone R. J., Eisch A. J., Gold S. J. Monteggia L. M. (2002) Neurobiology of depression. Neuron 34, 13 25.
38. Onishchenko N., Tamm C., Vahter M., Hokfelt T., Johnson J. A., Johnson D. A. Ceccatelli S. (2007) Developmental Exposure to Methylmercury Alters Learning and Induces Depression-like Behavior in Male Mice. Toxicol. Sci. 97, 428 437.
39. Porsolt R. D. (2000) Animal models of depression: utility for transgenic research. Rev. Neurosci. 11, 53 58.
40. Porsolt R. D., Bertin A. Jalfre M. (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327 336.
41. Post R. M. (2007) Role of BDNF in bipolar and unipolar disorder: Clinical and theoretical implications. J. Psychiatr. Res. 41, 979 990.
42. Quintana H., Butterbaugh G. J., Purnell W. Layman A. K. (2007) Fluoxetine monotherapy in attention-deficit/hyperactivity disorder and comorbid non-bipolar mood disorders in children and adolescents. Child Psychiatry Hum. Dev. 37, 241 253.
43. Rantamäki T., Hendolin P., Kankaanpää A., Mijatovic J., Piepponen P., Domenici E., Chao M. V., Männistö P. T. Castrén E. (2007) Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor trkb and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 32, 2152 2162.
44. Smith M. A., Makino S., Kvetnansky R. Post R. M. (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15, 1768 1777.
45. Sutherland J. E. Costa M. (2003) Epigenetics and the environment. Ann. N Y Acad. Sci. 983, 151 160.
46. Tao X., Finkbeiner S., Arnold D. B., Shaywitz A. J. Greenberg M. E. (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709 726.
47. Tsankova N. M., Berton O., Renthal W., Kumar A., Neve R. L. Nestler E. J. (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 9, 519 525.
48. Tsankova N., Renthal W., Kumar A. Nestler E. J. (2007) Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355 367.
49. Volkel P. Angrand P. O. (2007) The control of histone lysine methylation in epigenetic regulation. Biochimie 89, 1 20.
50. Wells J. Farnham P. J. (2002) Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods 26, 48 56.
51. Wong J. Y., Liberatore G. T., Donnan G. A. Howells D. W. (1997) Expression of brain-derived neurotrophic factor and TrkB neurotrophin receptors after striatal injury in the mouse. Exp. Neurol. 148, 83 91.